Statistics

Total Visits

Views
Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study15

Select a period of time:

Number of views in the range

Views
Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study6

Views

Views
August 20245
September 20240
October 20240
November 20240
December 20240
January 20251
February 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States4
United Kingdom1
 

Top cities views

Views
Chicago1